Evidence map›Paper›PMID 41659013›Full record

ArticleFrontiers in bioengineering and biotechnology2025

Correction: A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model.

Monica Marzagalli, Giorgia Pelizzoni, Arianna Fedi, Chiara Vitale, Fabrizio Fontana, Silvia Bruno, Alessandro Poggi, Alessandra Dondero, Maurizio Aiello, Roberta Castriconi and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Monica MarzagalliReact4life S.r.l, Genoa, Italy.
Giorgia PelizzoniDepartment of Biotechnology and Bioscience, University of Milano-Bicocca, Piazza Della Scienza, Milan, Italy.
Arianna FediNational Research Council, CNR-IEIIT, Genoa, Italy.
Chiara VitaleNational Research Council, CNR-IEIIT, Genoa, Italy.
Fabrizio FontanaDepartment of Pharmacological and Biomolecular Sciences (DiSFeB), University of Milan, Milan, Italy.
Silvia BrunoDepartment of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
Alessandro PoggiMolecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Alessandra DonderoDepartment of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
Maurizio AielloNational Research Council, CNR-IEIIT, Genoa, Italy.
Roberta CastriconiDepartment of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
Cristina BottinoDepartment of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
Silvia ScaglioneNational Research Council, CNR-IEIIT, Genoa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fbioe.2022.945149.].

Indexed as

3D human tumor modelcells infiltrationcells migrationimmune-organ-on-chipnatural killer cellsneuroblastoma

Identifiers

PMID41659013
PMCPMC12873478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.